Director/PDMR Shareholding

DXS International

05/12/2023 16:01

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231205:nGNE4NWz3W&default-theme=true


DXS INTERNATIONAL PLC

Notification of Director / PDMR Dealing

The Board of DXS International plc (the “Company”), the AQSE Growth Market
quoted clinical decision support developer and supplier of clinical decision
support systems has received notification and notified the market that on 4
December 2023 Mr Bob Sutcliffe purchased a total of 400,000 Ordinary Shares in
the Company at a price of 2.5p per share on behalf of himself and others.

One of the other persons acquiring beneficial ownership of Ordinary Shares as
a result of Mr Sutcliffe’s purchase is David Immelman, the DXS Chief
Executive, who has acquired a beneficial interest in 40,000 Ordinary Shares.
Following this transaction Mr Immelman, and persons connected to him, have an
interest in DXS Ordinary Shares of 6,563,829 Ordinary Shares representing
10.25% of the issued share capital of the Company.

 1   Details of the person discharging managerial responsibilities / person closely associated                                                                                                                                        
 a)  Name                                                         David Immelman                                                                                                                                                      
 2   Reason for the notification                                                                                                                                                                                                      
 a)  Position/status                                              Chief Executive                                                                                                                                                     
 b)  Initial notification /Amendment                              Initial                                                                                                                                                             
 3   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor                                                                                                                    
 a)  Name                                                         DXS INTERNATIONAL PLC                                                                                                                                               
 b)  LEI                                                          2138001R1KEUWTXEVJ44                                                                                                                                                
 4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted                                
 a)  Description of the financial instrument, type of instrument  Ordinary Shares of 0.33p each                                                                                                                                       
                                                                                                                                                                                                                                      
     Identification code                                          ISIN GB00B2Q6HZ92                                                                                                                                                   
                                                                                                                                                                                                                                      
 b)  Nature of the transaction                                    Issue of new shares                                                                                                                                                 
 c)  Price(s) and volume(s)                                                                                                                                                                                                           
                                                                                                           Price(s)                                 Volume(s)                                                                         
                                                                                                           2.5p                                     40,000                                                                            
                                                                                                                                                                                                                                      
 d)  Aggregated information                                                                                                                                                                                                           
                                                                                                                                                                                                                                      
     - Aggregated volume                                                                                                                                                                                                              
                                                                                                                                                                                                                                      
     - Price                                                                                                                                                                                                                          
                                                                                                                                                                                                                                      
 e)  Date of the transaction                                      4 December 2023                                                                                                                                                     
 f)  Place of the transaction                                     Aquis Stock Exchange                                                                                                                                                

The Directors of DXS International plc accept responsibility for this
announcement.

Enquiries:

 David Immelman (Chief Executive) DXS International plc      01252 719800 david@dxs-systems.com  
 Wrecclesham House Wrecclesham Road Farnham Surrey GU10 4PS                                      
 www.dxs-systems.co.uk                                                                           



 Corporate Advisor                              
 David Papworth City & Merchant  0207 101 7676  



 Corporate Broker                                 
 Hybridan LLP Claire Louise Noyce  020 3764 2341  

Note to Editors:

DXS International presents up to date treatment guidelines and
recommendations, from Clinical Commissioning Groups and other trusted NHS
sources, to doctors, nurses and pharmacists in their workflow and during the
patient consultation. This effective clinical decision support ultimately
translates to improved healthcare outcomes delivered more cost effectively
which should significantly contribute towards the NHS achieving its projected
efficiency savings